Imunon, Inc. (IMNN)

Imunon Statistics

Total Valuation

Imunon has a market cap or net worth of $10.16 million. The enterprise value is $6.01 million.

Market Cap	10.16M
Enterprise Value	6.01M

Important Dates

The last earnings date was Thursday, November 13, 2025, before market open.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Imunon has 3.07 million shares outstanding. The number of shares has increased by 57.50% in one year.

Current Share Class	3.07M
Shares Outstanding	3.07M
Shares Change (YoY)	+57.50%
Shares Change (QoQ)	+100.41%
Owned by Insiders (%)	1.11%
Owned by Institutions (%)	7.03%
Float	3.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.35
P/TBV Ratio	2.49
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.27.

Current Ratio	1.73
Quick Ratio	1.25
Debt / Equity	0.27
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -233.50% and return on invested capital (ROIC) is -124.09%.

Return on Equity (ROE)	-233.50%
Return on Assets (ROA)	-77.72%
Return on Invested Capital (ROIC)	-124.09%
Return on Capital Employed (ROCE)	-303.46%
Revenue Per Employee	n/a
Profits Per Employee	-$573,176
Employee Count	25
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -67.23% in the last 52 weeks. The beta is 1.93, so Imunon's price volatility has been higher than the market average.

Beta (5Y)	1.93
52-Week Price Change	-67.23%
50-Day Moving Average	4.15
200-Day Moving Average	8.56
Relative Strength Index (RSI)	27.87
Average Volume (20 Days)	38,614

Short Selling Information

The latest short interest is 158,811, so 5.17% of the outstanding shares have been sold short.

Short Interest	158,811
Short Previous Month	200,403
Short % of Shares Out	5.17%
Short % of Float	5.23%
Short Ratio (days to cover)	3.02

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-14.54M
Pretax Income	-14.33M
Net Income	-14.33M
EBITDA	-14.28M
EBIT	-14.54M
Earnings Per Share (EPS)	-$9.54

Balance Sheet

The company has $5.25 million in cash and $1.10 million in debt, giving a net cash position of $4.15 million or $1.35 per share.

Cash & Cash Equivalents	5.25M
Total Debt	1.10M
Net Cash	4.15M
Net Cash Per Share	$1.35
Equity (Book Value)	4.08M
Book Value Per Share	1.41
Working Capital	3.06M

Cash Flow

In the last 12 months, operating cash flow was -$14.66 million and capital expenditures -$291,890, giving a free cash flow of -$14.95 million.

Operating Cash Flow	-14.66M
Capital Expenditures	-291,890
Free Cash Flow	-14.95M
FCF Per Share	-$4.87

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Imunon does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-57.50%
Shareholder Yield	-57.50%
Earnings Yield	-141.00%
FCF Yield	-147.13%

Analyst Forecast

The average price target for Imunon is $182.61, which is 5,302.66% higher than the current price. The consensus rating is "Buy".

Price Target	$182.61
Price Target Difference	5,302.66%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 7, 2025. It was a forward split with a ratio of 1.15:1.

Last Split Date	Aug 7, 2025
Split Type	Forward
Split Ratio	1.15:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a